Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
09/2003
09/10/2003CN1440971A Vitronectin receptor antagnist, its preparation and use
09/09/2003US6617452 Liquid-liquid extraction being carried out in the first stage at a pH-value of about 4; treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.
09/09/2003US6617359 4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
09/09/2003US6616913 Composition and method for treatment of otitis media
09/04/2003WO2003072704A2 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/04/2003WO2003072601A1 Method for producing hypoallergenic major birch pollen allergens rbet v 1
09/04/2003WO2003072580A1 1-[ALKYL], 1-[HETEROARYL)ALKYL] AND 1-[ARYL)ALKYL]-7-(PYRIMIDIN-4-YL)-IMADAZO[1,2-a]PYRIMIDIN-5(1H)-ONE DERIVATIVES
09/04/2003WO2003072579A1 HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9- TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES
09/04/2003WO2003072578A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
09/04/2003WO2003072570A1 Antidiabetic agents
09/04/2003WO2003072550A1 Novel fused ring indazole compounds
09/04/2003WO2003072545A1 Cyclic amine compound and ccr3 inhibitory drug containing the same as active ingredient
09/04/2003WO2003072141A1 Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
09/04/2003WO2003072114A1 Vascular therapeutics
09/04/2003WO2003072067A2 Compositions and methods for treating epithelial and retinal tissue diseases
09/04/2003WO2003072066A2 Compositions and methods for the treatment of glaucoma and ocular hypertension
09/04/2003WO2003072029A2 Methods of extending corneal graft survival
09/04/2003WO2003072027A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
09/04/2003WO2003048120A3 2-aryl pyrrologpyrimidines for a1 and a3 receptors
09/04/2003WO2003043660A3 Composition for stabilizing hyaluronic acid
09/04/2003WO2003011860A3 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE
09/04/2003WO2002064792A3 Molecules for disease detection and treatment
09/04/2003WO2002046426A3 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
09/04/2003WO2002020769A9 Human and mouse targeting peptides identified by phage display
09/04/2003WO2002015892A3 Combination comprising an insulin secretion enhancer and an active ingredient selected from hmg-co-a reductase inhibitors and ace inhibitors
09/04/2003WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
09/04/2003US20030167033 Systems and methods for photodynamic therapy
09/04/2003US20030166945 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
09/04/2003US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents
09/04/2003US20030166872 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders
09/04/2003US20030166859 Controlling cell proliferation, cell differentiation; anticancer agents
09/04/2003US20030166725 Compounds active at the glucocorticoid receptor
09/04/2003US20030166723 Gamma-linolenic acid, di-homo-gamma-linolenic acid and derivatives
09/04/2003US20030166711 A non-peptide and a non- nucleotide compound, culture product of penicillium sp. SPF-3059
09/04/2003US20030166708 Cyclic substituted aminomethyl compounds and medicaments comprising these compounds
09/04/2003US20030166705 Water-based liquid preparation
09/04/2003US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166689 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/04/2003US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer
09/04/2003US20030166671 Amorphous polymorphic forms by grinding or pulverizing; having a distinctive X-ray powder diffraction pattern; anti-tumor and -carcinogenic agents; administered by mouth, intravenous injection and inhalation
09/04/2003US20030166668 Substituted heteroarylalkanoic acids
09/04/2003US20030166652 Chemical compounds
09/04/2003US20030166646 Nitric oxide synthase inhibitors such as 4-(morpholin-4-yl methyl)-4,5-dihydro-1,3-thiazol-2-ylamine, administered for prophylaxis of neurodegenerative diseases
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166634 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
09/04/2003US20030166633 Pyridinylimidazoles
09/04/2003US20030166632 Method for treating a disease or condition responsive to opening of C1C-2 channel
09/04/2003US20030166630 Amino acid derivatives and their use as medicines
09/04/2003US20030166581 Coadministered with caffeine, for prevention of seizures; for treatment of Parkinson's/Alzheimer's disease; dietetics; smoking cessation
09/04/2003US20030166537 Use of a gial cell line-derived growth factor (GDNF) or a functionally active derivative or part thereof and/or an agonist which substitutes the functional activity of GDNF, and/ or a nucleic acid containing at least a nucleotide
09/04/2003US20030166277 Targeted vaccine delivery systems
09/04/2003US20030165569 Composition for topical substance delivery
09/04/2003US20030165545 Contact lenses; mixture of oil, water and surfactants
09/04/2003US20030165485 Functional role and potential therapeutic use of Reelin, Gas6 and Protein S in relation to adult neural stem or progenitor cells
09/04/2003US20030165449 Lipase inhibiting composition
09/04/2003CA2477409A1 Process for the preparation of hypoallergenic major birch pollen allergen rbet v 1
09/04/2003CA2477283A1 Vascular therapeutic methods and compositions involving the reduction or prevention of c-jun mediated processes
09/04/2003CA2477049A1 Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
09/04/2003CA2476994A1 Methods of extending corneal graft survival
09/04/2003CA2476630A1 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof
09/04/2003CA2475773A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
09/03/2003EP1340759A1 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives
09/03/2003EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/03/2003EP1340500A1 Antidiabetic agents
09/03/2003EP1339834A2 Enzymes
09/03/2003EP1339721A2 Hydroxyesters of 7-desmethylrapamycin
09/03/2003EP1339715A2 Heterocyclic ether substituted imidazoquinolines
09/03/2003EP1339711A1 Aminothiazoles and their use as adenosine receptor antagonists
09/03/2003EP1339710A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives
09/03/2003EP1339709A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives
09/03/2003EP1339698A2 Pyrimidine derivatives
09/03/2003EP1339691A1 Novel compounds
09/03/2003EP1339687A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents
09/03/2003EP1339679A1 3-arylindole derivatives and their use as cb2 receptor agonists
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/03/2003EP1339668A2 Bisubstituted carbocyclic cyclophilin binding compounds and theirus
09/03/2003EP1339458A2 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity
09/03/2003EP1339438A2 Methods for preventing transplant rejection in the eye
09/03/2003EP1339424A2 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors
09/03/2003EP1339418A1 Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers
09/03/2003EP1339414A2 L-histidine in ophthalmic solutions
09/03/2003EP1339402A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
09/03/2003EP1339386A2 Reversible gelling system for ocular drug delivery
09/03/2003EP1060178B1 Heterocyclic compounds as inhibitors of rotamase enzymes
09/03/2003EP0977741B1 Substituted phenyl derivatives, their preparation and use
09/03/2003EP0973792B1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
09/03/2003EP0969812B1 Ophthalmic compositions including glycerin and propylene glycol
09/03/2003CN1440411A Aryl and heteroaryl diazabicycloalkanes, their preparation and use
09/03/2003CN1440409A Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
09/03/2003CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/03/2003CN1440405A Sulfonyl-pyrrolidine derivatives useful for treatment of neurological disorders
09/03/2003CN1440400A Bicyelyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides
09/03/2003CN1440396A Colchinol derivatives as angiogenesis inhibitors
09/03/2003CN1440395A COLCHINOL derivatives as vascular damaging agents
09/03/2003CN1440295A Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol monno-oligosaccharide
09/03/2003CN1440287A Method of treating peripheral vascular diseases, peripheral neuropathies, and automatic neuropathies
09/03/2003CN1440281A Medicine for reducing intraocular pressure
09/02/2003US6613917 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
09/02/2003US6613802 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
1 ... 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 ... 531